Treatment adherence in patients with multiple sclerosis: risk factors

Treatment adherence in patients with multiple sclerosis: risk factors

Introduction: Adherence is a modifiable factor to disease-modifying treatments response in patients with multiple sclerosis (MS). Our objective is to assess the risk factors associated with inadequate adherence. Method: Retrospective study through review of medical records and review of the database...

Full description

Saved in:

Bibliographic Details
Main Authors:	L.A. Rodríguez de Antonio, R. Fernández de Córdoba-García, N. Herrero-Muñoz, A. Ontañón-Nasarre, I. García-Castañón
Format:	Article
Language:	English
Published:	Elsevier España 2025-05-01
Series:	Neurología (English Edition)
Subjects:	Esclerosis múltiple Adherencia Tratamiento Farmacia Dispensación Deterioro cognitivo
Online Access:	http://www.sciencedirect.com/science/article/pii/S2173580825000367
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Causas de la derivación de pacientes por farmacéuticos comunitarios en Madrid: un análisis del estudio Conexión Futuro
by: Amparo Bonilla Guijarro, et al.
Published: (2025-07-01)

Evaluación de un Sistema de Gestión de Riesgos para prevenir el deterioro cognitivo en consumidores crónicos de cocaína
by: Richard Emilio Minas-Paredes, et al.
Published: (2025-04-01)

Autoimmune eye diseases in multiple sclerosis
by: M.L. Martínez Ginés, et al.
Published: (2025-07-01)

Multiple sclerosis and rheumatic diseases: Behçet disease, sarcoidosis, and Sjögren syndrome
by: M.A. Hernández, et al.
Published: (2025-07-01)

Other autoimmune diseases and multiple sclerosis
by: S. Martínez-Yélamos, et al.
Published: (2025-07-01)

Intervenciones farmacéuticas en el servicio de asistencia en nuevos medicamentos
by: Damià Barris Blundell, et al.
Published: (2025-07-01)

Deterioro cognitivo y demencia: un nuevo desafío en nuestro consultorio
by: Alejandro Daín
Published: (2024-10-01)

Multiple sclerosis and rheumatic diseases: Rheumatoid arthritis, antiphospholipid syndrome, and systemic lupus erythematosus
by: M.A. Hernández, et al.
Published: (2025-07-01)

Explorando la conexión entre dolor, edad, sexo, calidad de vida, capacidad funcional y sueño. Un análisis en farmacia comunitaria
by: Daniel Reyes Estévez, et al.
Published: (2025-07-01)

Prevalence of multiple sclerosis in Spain. Estimates from the Primary Care Clinical Database (BDCAP)
by: L. Cayuela, et al.
Published: (2025-06-01)

Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2022-10-01)

Buenas prácticas de dispensación de antibióticos en farmacias comunitarias de la provincia de Córdoba, Argentina
by: Pedro Domingo Armando, et al.
Published: (2025-04-01)

Presence of Cognitive Deterioration and Anatomical-Clinical Topography in Patients with Epilepsy in Cienfuegos
by: Rolando Lázaro Rivera López, et al.
Published: (2015-02-01)

La carga anticolinérgica en ancianos
by: María Rodríguez Casal
Published: (2025-01-01)

Seguridad en la dispensación de alimentos para usos médicos especiales destinados a la población pediátrica: a propósito de un caso
by: Montserrat Viñas-Bastart, et al.
Published: (2025-07-01)

Fear of Relapse Scale: Spanish version and psychometric characteristics in a sample of patients with Relapsing-Remitting multiple sclerosis
by: Y. Broche-Pérez, et al.
Published: (2024-11-01)

Pediatric multiple sclerosis in Venezuela
by: Joaquín A. Peña, et al.
Published: (2012-04-01)

Epidemiological, clinical and imaging profile of Multiple Sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2021-12-01)

Autoimmune skin diseases in multiple sclerosis
by: M. Roncero Riesco, et al.
Published: (2025-07-01)

Characterization of Patients with Uncontrolled Arterial Hypertension in Relation to Adherence to Treatment
by: Yadelaicy Ochoa González, et al.
Published: (2022-09-01)

Evaluación de la efectividad de los Sistemas Personalizados de Dosificación (SPD) en la incidencia de PRM/RNM y problemas de salud en una farmacia comunitaria. Estudio de cohortes retrospectivo
by: Elena Valles Martín, et al.
Published: (2025-04-01)

There is much to be learnt about the costs of multiple sclerosis in Latin America
by: Marina Romano, et al.
Published: (2013-08-01)

Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact
by: Juan Ignacio Rojas, et al.
Published: (2016-03-01)

Tiempo de almacenamiento del cormo y su efecto en el crecimiento y producción de plátano (Musa AAB) Dominico Hartón
by: Manuel Aristizábal L
Published: (2013-12-01)

Therapeutic Adherence in Patients with Arterial Hypertension
by: Liens Hernández Quintero, et al.
Published: (2021-09-01)

Una herramienta efectiva, un compromiso compartido: INFO-SPD
by: Vicente J. Baixauli
Published: (2025-07-01)

Caracterización clínica de pacientes con esclerosis múltiple
by: Roberto Luis Lotti Mesa, et al.
Published: (2023-03-01)

Family support and adherence to treatment in people affected by tuberculosis
by: Cesar Raul Castro Galarza, et al.
Published: (2020-10-01)

Multiple sclerosis mortality trends in Spain from 1981 to 2020
by: L. Cayuela, et al.
Published: (2025-07-01)

Causalidad del deterioro cognitivo en cirugía cardiaca de pacientes atendidos en un hospital de tercer nivel de atención
by: Angélica Porras-Juárez, et al.
Published: (2025-06-01)

Deterioro cognitivo en la pospandemia COVID-19. Estudio de prevalencia
by: Ana M. García-Rodríguez, et al.
Published: (2025-04-01)

Impact of COVID-19 on physiotherapy for patients with multiple sclerosis in Spain: Adaptation and challenges in the implementation of telerehabilitation
by: I. Yeregui-Prieto, et al.
Published: (2025-04-01)

Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis
by: Juan Ignacio Rojas, et al.
Published: (2012-08-01)

The prevalence of sexual dysfunction and erectile dysfunction in men with multiple sclerosis: A systematic review and meta-analysis
by: V. Shaygannejad, et al.
Published: (2025-01-01)

ENCOMS: Argentinian survey in cost of illness and unmet needs in multiple sclerosis
by: Celica Ysrraelit, et al.
Published: (2014-05-01)

Adherencia al tratamiento antibiótico prescrito: una comparación entre duración corta y larga desde la perspectiva de los farmacéuticos comunitarios
by: Pilar Zafrilla Rentero, et al.
Published: (2025-05-01)

Fallo terapéutico en esclerosis múltiple remitente-recurrente: definición y algoritmo para su manejo, un consenso de expertos
by: Jimena García, et al.
Published: (2025-02-01)

Adherencia terapéutica y factores psicosociales y clínicos de personas con hipotiroidismo primario
by: Evelin del Valle Cala, et al.
Published: (2023-12-01)

The sensitive Amnesia Light and Brief Assessment (ALBA) is a valid 3-min test of 4 tasks indicative of mild cognitive deficits
by: A. Bartos, et al.
Published: (2025-07-01)

Association between Depression and Cognitive Impairment in Older Adults from a Comprehensive Care Center in Lima
by: Juliet Guillén, et al.
Published: (2022-08-01)